scholarly journals CSF1R inhibition by small molecule affects T-helper cell differentiation independently of microglia depletion

2021 ◽  
Author(s):  
Fengyang Lei ◽  
Naiwen Cui ◽  
Chengxin Zhou ◽  
James Chodosh ◽  
Demetrios D Vavvas ◽  
...  

Colony-stimulating factor 1 receptor (CSF1R) inhibition has been proposed as a specific method for microglia depletion. However, recent work revealed that in addition to microglia, CSF1R inhibition also affects other innate immune cells, such as peripheral monocytes and tissue-resident macrophages of the lung, liver, spleen, and peritoneum. Here, we show that this effect is not restricted to innate immune cells only, but extends to the adaptive immune compartment. CSF1R inhibition alters the transcriptional profile of bone marrow cells that control T helper cell activation. In vivo or ex vivo inhibition of CSF1R profoundly changes the transcriptional profile of CD4+ cells and suppresses Th1 and Th2 differentiation in directionally stimulated and unstimulated cells and independently of microglia depletion. Given that T cells also contribute in CNS pathology, these effects may have practical implications in the interpretation of relevant experimental data.

1988 ◽  
Vol 15 (1-3) ◽  
pp. 169-174 ◽  
Author(s):  
U. Hämmerling ◽  
M. Toulon ◽  
R. G. E. Palfree ◽  
M. K. Hoffmann

2007 ◽  
Vol 178 (3) ◽  
pp. 1468-1476 ◽  
Author(s):  
Elke Scandella ◽  
Katja Fink ◽  
Tobias Junt ◽  
Beatrice M. Senn ◽  
Evelyn Lattmann ◽  
...  

1998 ◽  
Vol 30 (8) ◽  
pp. 4270-4274 ◽  
Author(s):  
G.A van Seventer ◽  
R.T Semnani ◽  
E.M Palmer ◽  
B.L McRae ◽  
J.M van Seventer

2017 ◽  
Author(s):  
Johan Henriksson ◽  
Xi Chen ◽  
Tomás Gomes ◽  
Ubaid Ullah ◽  
Kerstin B Meyer ◽  
...  

AbstractT helper type 2 (Th2) cells are important regulators of mammalian adaptive immunity and have relevance for infection, auto-immunity and tumour immunology. Using a newly developed, genome-wide retroviral CRISPR knock-out (KO) library, combined with RNA-seq, ATAC-seq and ChIP-seq, we have dissected the regulatory circuitry governing activation (including proliferation) and differentiation of these cells. Our experiments distinguish cell activationversusdifferentiation in a quantitative framework. We demonstrate that these two processes are tightly coupled and are jointly controlled by many transcription factors, metabolic genes and cytokine/receptor pairs. There is only a small number of genes regulating differentiation without any role in activation. Our study provides an atlas for the T helper cell regulatory network, pinpointing key players of Th2 differentiation and demonstrating remarkable plasticity between the diverse T helper cell fates. We provide an online resource for interactive data querying at:http://data.teichlab.org.


2002 ◽  
Vol 20 (12) ◽  
pp. 2904-2905 ◽  
Author(s):  
H. Bosshart ◽  
Stephen M. Ansell ◽  
Diane F. Jelinek ◽  
Peter J. Wettstein ◽  
Thomas E. Witzig

2013 ◽  
Vol 7 ◽  
pp. S31
Author(s):  
E. Sonnenberg ◽  
R. Glauben ◽  
P. Mascagni ◽  
B. Siegmund

1991 ◽  
Vol 5 (13) ◽  
pp. 2770-2776 ◽  
Author(s):  
Randolph J. Noelle ◽  
E. Charles Snow

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Xin He ◽  
Bo Liang ◽  
Ning Gu

Atherosclerosis is nowadays recognized as a chronic inflammatory disease of large arteries. In recent years, cellular and molecular biology studies on atherosclerosis confirmed that the occurrence and development are related to inflammation and autoimmunity. A variety of immune cells, cytokines, and transcription factors are involved in this process. Current studies found that T helper cell 17, regulatory T cells, and their cytokines play an important role in the development of atherosclerosis and vulnerable plaque rupture. Here, we provide a review of the up-to-date applications of T helper cell 17, regulatory T cells, cytokines, and their balance in the prognosis and therapy of atherosclerosis.


Sign in / Sign up

Export Citation Format

Share Document